Advertisement

Topics

A Norwegian Immuno-Oncology Biotech is preparing for an IPO

10:13 EST 8 Mar 2017 | Labiotech.eu

BerGenBio has announced an IPO on Oslo Børs in Norway to boost its small molecule cancer drugs. Moreover, the company announced a new clinical collaboration with Merck. BerGenBio is a clinical-stage company, which is focused on developing a pipeline of ...

This awesome article A Norwegian Immuno-Oncology Biotech is preparing for an IPO appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: A Norwegian Immuno-Oncology Biotech is preparing for an IPO

NEXT ARTICLE

More From BioPortfolio on "A Norwegian Immuno-Oncology Biotech is preparing for an IPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...